NEW POTENTIAL OF MEXICOR IN THE TREATMENT OF CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME

NEW POTENTIAL OF MEXICOR IN THE TREATMENT OF CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME

The study included 60 patients, aged 45-65 years, with metabolic syndrome (MS), Functional Class II-III chronic heart failure (CHF), and recent myocardial infarction (MI). The participants were randomised into 2 groups (n=30 in each). The main group received standard CHF therapy and Mexicor (0,4 g/d...

Full description

Bibliographic Details
Main Authors:	M. E. Statsenko, E. D. Evtereva, S. V. Turkina, S. V. Fabritskaya, O. E. Sporova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2010-12-01
Series:	Российский кардиологический журнал
Subjects:	metabolic syndrome chronic heart failure mexicor left ventricular remodeling diastolic function insulin resistance carbohydrate and lipid metabolism chronic inflammation syndrome
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1511

Similar Items

MEXICOR EFFECTIVENESS IN PATIENTS WITH CHRONIC HEART FAILURE AND METABOLIC SYNDROME
by: M. E. Statsenko, et al.
Published: (2009-12-01)

CARDIONATE IN COMBINED THERAPY OF ISCHEMIC CHRONIC HEART FAILURE AMONG PATIENTS WITH METABOLIC SYNDROME
by: M. E. Statsenko, et al.
Published: (2010-08-01)

MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01)

Heart pathology in patients with arterial hypertension and metabolic syndrome
by: G. Kh. Sharipova, et al.
Published: (2008-12-01)

MEXICOR EFFECTIVENESS IN PATIENTS WITH BRADYARRHYTHMIAS
by: A. A. Kotlyarov, et al.
Published: (2009-06-01)

The specific features of left cardiac cavity remodeling in patients with chronic obstructive pulmonary disease and chronic cor pulmonale
by: Andrey Vladislavovich Strutynskiy, et al.
Published: (2010-09-01)

Efficacy of a cytoprotector mexicor in urgent cardiology
by: A P Golikov, et al.
Published: (2004-04-01)

Remodeling variants and diastolic filling at various stages of diastolic chronic heart failure
by: I. A. Zavodchikova, et al.
Published: (2005-04-01)

Biomarkers of Liver in Patients with Chronic Pancreatitis Associated with Metabolic Syndrome
by: Gulchehra R. Yuldasheva, et al.
Published: (2014-03-01)

Yacton and mexicor influence on prooxidant-antioxidant homeostasis and protein synthesis in the myocardium of rats in conditions of doxorubicin cardiomyopathy
by: E. A. Raketskaya, et al.
Published: (2015-04-01)

EFFECTS OF MILDRONATE, AS A PART OF COMBINED HEART FAILURE THERAPY, ON CARBOHYDRATE AND LIPID METABOLISM AND OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2010-04-01)

Left ventricular remodeling patterns in children with metabolic syndrome
by: Veronica ESANU, et al.
Published: (2020-10-01)

Left ventricular structure and function in chronic renal disease
by: V. V. Skibitsky, et al.
Published: (2009-12-01)

Endothelium protecting properties of taurin in chronic heart failure with type 2 diabetes
by: M. E. Stacenko, et al.
Published: (2016-04-01)

CARBOHYDRATE METABOLISM DISTURBANCES: THERAPEUTIC POTENTIAL IN METABOLIC SYNDROME
by: I. V. Kryuchkova, et al.
Published: (2009-04-01)

The relationship of risk factors and heart remodeling in patients with metabolic syndrome and arterial hypertension
by: E. L. Polozova, et al.
Published: (2021-01-01)

Trimetazidine effects on heart and kidney functional status, and quality of life in long-term complex treatment of chronic heart failure in elderly patients
by: M. E. Statsenko, et al.
Published: (2005-10-01)

Leptin and Adiponectin Levels in Patients with Chronic Hepatitis C with Carbohydrate and Lipid Metabolism Disorders
by: T. V. Antonova, et al.
Published: (2014-10-01)

Yakton and mexicor influence on the indicators of glycolysis, glyconeogenesis and energoproduct function of mitochondria in the rats’ myocardium in the conditions of doxorubicin cardiomyopathy
by: E. A. Raketskaya, et al.
Published: (2015-08-01)

THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION
by: M. V. Kurkina, et al.
Published: (2017-11-01)

Treatment of chronic heart failure with a very low dose of antibodies to C-fragment of type 1 angiotensin II receptor
by: T. M. Poponina, et al.
Published: (2009-08-01)

Impact of Pulse Wave Velocity and Parameters Reflecting Android Type Fat Distribution on Left Ventricular Diastolic Dysfunction in Patients with Chronic Coronary Syndromes
by: Marlena Paniczko, et al.
Published: (2020-12-01)

BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF THE HEART DAMAGE IN METABOLIC SYNDROME
by: R. A. Libis, et al.
Published: (2015-04-01)

Cardiac troponin T in coronary heart disease patients with chronic heart failure
by: V. S. Nikiforov, et al.
Published: (2005-02-01)

ANTIISCHEMIC AND ANTIARRHYTHMIC EFFECTS OF SIMVASTATIN IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: T. V. Pinchuk, et al.
Published: (2013-12-01)

ACE INHIBITOR ZOFENOPRIL IN COMPLEX THERAPY OF CHRONIC HEART FAILURE AND DILATED CARDIOMYOPATHY
by: Z. T. Astakhova, et al.
Published: (2010-04-01)

CHARACTERISTICS OF COMBINED USE OF MEXICOR TOGETHER WITH SOME ANTIARRHYTHMIC DRUGS IN ACUTE OCCLUSION OF CORONARY ARTERY IN EXPERIMENTAL STUDY
by: A. A. Kotljarov, et al.
Published: (2003-10-01)

Metabolic syndromes, carbohydrate and lipid metabolism disorders in helminthic infections: review of the literature
by: E. A. Golovach, et al.
Published: (2018-12-01)

DYSLIPIDEMIA ROLE IN THE DEVELOPMENT OF METABOLIC SYNDROME
by: M. V. Antonyuk, et al.
Published: (2011-10-01)

Risk factors for diastolic left ventricular myocardial dysfunction in patients with chronic kidney disease
by: T E Rudenko, et al.
Published: (2018-09-01)

Left Ventricular Remodeling in Patients with Stable Angina Complicated by Heart Failure with Reduced and Preserved Ejection Fraction
by: Denesyuk V., et al.
Published: (2016-09-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome.
by: V. A. Vasylenko
Published: (2015-09-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome
by: Vasylenko V.A.
Published: (2015-09-01)

FEATURES OF HEMODYNAMICS OF LIVER AND HEART IN PATIENTS WITH VIRAL CIRRHOSIS
by: M. V. Chistyakova, et al.
Published: (2014-02-01)

Diagnosis of chronic heart failure in patients with chronic obstructive pulmonary disease
by: V I Koliev, et al.
Published: (2019-06-01)

CORRECTION OF MICROCIRCULATORY DISORDERS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHRONIC HEART FAILURE PATIENTS
by: M. E. Statsenko, et al.
Published: (2016-12-01)

Association of Heart Failure with Preserved Ejection Fraction and Components of Metabolic Syndrome
by: Anda-Mihaela Cerghizan, et al.
Published: (2015-12-01)

Heart remodeling in patients with arterial hypertension and normal glucose metabolism or Type 2 diabetes mellitus
by: E. I. Nachkina
Published: (2009-04-01)

Heart pathology in young and middle-aged patients with metabolic syndrome
by: N. I. Gromnatsky, et al.
Published: (2007-10-01)

Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study
by: Jeong Yeon Kim, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_eqhkhecu67s6pdh6p2f9h5umsm